^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.4
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}
Key Seconda
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

                      The Mixed Procedure

                       Model Information

     Data Set                     WORK.TARGET_1            
     Dependent Variable           CHG                      
     Covariance Structure         Unstructured             
     Subject Effect               id                       
     Estimation Method            REML                     
     Residual Variance Method     None                     
     Fixed Effects SE Method      Kenward-Roger            
     Degrees of Freedom Method    Kenward-Roger            


 
 
 
 
 
 
 
 
 
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: In this supplemental analysis, the main ICE of treatm
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.4
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}
Key Seconda
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

                      The Mixed Procedure

                    Class Level Information
 
      Class      Levels    Values

      id             39    10631001 10631002 10631003    
                           11601002 11601006 11601007    
                           13031001 13031004 13581001    
                           13581010 13581014 13991001    
                           13991002 13991004 13991007    
                           13991009 13991010 16591001    
                           16591003 16591006 17601002    
                           17601003 17601005 17601007    
                           17601012 17601014 17601025    
                           17661002 17661004 17661006    
                           19691001 19731001 19731002    
                           19731004 19731006 19831001    
                           19831005 19831008 19901003    
      AVISITN         4    1 4 8 12                      
      SSNRISN         2    1 2                           
      trtn            3    1 2 3                         
 
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: In this supplemental analysis, the main ICE of treatm
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.4
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}
Key Seconda
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

                      The Mixed Procedure

                          Dimensions

              Covariance Parameters            10
              Columns in X                     35
              Columns in Z                      0
              Subjects                         39
              Max Obs per Subject               4


                    Number of Observations

          Number of Observations Read             124
          Number of Observations Used             124
          Number of Observations Not Used           0


 
 
 
 
 
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: In this supplemental analysis, the main ICE of treatm
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.4
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}
Key Seconda
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

                      The Mixed Procedure

                       Iteration History
 
  Iteration    Evaluations    -2 Res Log Like       Criterion

          0              1       301.70634179                
          1              2       253.00784514      0.00612121
          2              1       252.79715858      0.00025008
          3              1       252.78920556      0.00000062
          4              1       252.78918648      0.00000000


                   Convergence criteria met.                    


                Covariance Parameter Estimates
 
                Cov Parm    Subject    Estimate

                UN(1,1)     id           0.5774
                UN(2,1)     id           0.2791
                UN(2,2)     id           0.6289
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: In this supplemental analysis, the main ICE of treatm
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.4
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}
Key Seconda
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

                      The Mixed Procedure

                Covariance Parameter Estimates
 
                Cov Parm    Subject    Estimate

                UN(3,1)     id           0.3284
                UN(3,2)     id           0.5746
                UN(3,3)     id           1.0126
                UN(4,1)     id           0.3932
                UN(4,2)     id           0.2982
                UN(4,3)     id           0.5275
                UN(4,4)     id           0.5815


                        Fit Statistics

             -2 Res Log Likelihood           252.8
             AIC (Smaller is Better)         272.8
             AICC (Smaller is Better)        275.2
             BIC (Smaller is Better)         289.4
 
 
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: In this supplemental analysis, the main ICE of treatm
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.4
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}
Key Seconda
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

                      The Mixed Procedure

                Null Model Likelihood Ratio Test
 
                  DF    Chi-Square      Pr > ChiSq

                   9         48.92          <.0001


                 Type 3 Tests of Fixed Effects
 
                          Num     Den
      Effect               DF      DF    F Value    Pr > F

      BASE                  1      31      52.20    <.0001
      trtn                  2    30.3       0.08    0.9263
      AVISITN               3    24.8       0.58    0.6329
      AVISITN*trtn          6    29.2       0.76    0.6085
      BASE*AVISITN          3    24.4       0.47    0.7040
      SSNRISN               1      30       1.43    0.2409
      AVISITN*SSNRISN       3    24.6       0.52    0.6710
 
 
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: In this supplemental analysis, the main ICE of treatm
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.4
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}
Key Seconda
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

                      The Mixed Procedure

                      Least Squares Means
 
                Analysis                       Standard
 Effect         Visit (N)    trtn   Estimate      Error     DF

 AVISITN*trtn            1   1       -0.5614     0.2736     34
 AVISITN*trtn            1   2       -0.3583     0.2287     34
 AVISITN*trtn            1   3       -0.2502     0.2398     34
 AVISITN*trtn            4   1       -0.4499     0.2984   27.5
 AVISITN*trtn            4   2       -0.5206     0.2467   27.3
 AVISITN*trtn            4   3       -0.4149     0.2722   28.2
 AVISITN*trtn            8   1       -0.6652     0.3827   27.1
 AVISITN*trtn            8   2       -0.7832     0.3391   29.8
 AVISITN*trtn            8   3       -0.5078     0.3508   27.9
 AVISITN*trtn           12   1       -0.7554     0.3144   26.2
 AVISITN*trtn           12   2       -0.9197     0.2906   28.3
 AVISITN*trtn           12   3       -0.9805     0.2795   26.4

 
 
 
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: In this supplemental analysis, the main ICE of treatm
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.4
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}
Key Seconda
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

                      The Mixed Procedure

                      Least Squares Means
 
                Analysis
 Effect         Visit (N)    trtn   t Value   Pr > |t|    Alpha

 AVISITN*trtn            1   1        -2.05     0.0479     0.05
 AVISITN*trtn            1   2        -1.57     0.1263     0.05
 AVISITN*trtn            1   3        -1.04     0.3040     0.05
 AVISITN*trtn            4   1        -1.51     0.1431     0.05
 AVISITN*trtn            4   2        -2.11     0.0442     0.05
 AVISITN*trtn            4   3        -1.52     0.1385     0.05
 AVISITN*trtn            8   1        -1.74     0.0936     0.05
 AVISITN*trtn            8   2        -2.31     0.0280     0.05
 AVISITN*trtn            8   3        -1.45     0.1589     0.05
 AVISITN*trtn           12   1        -2.40     0.0237     0.05
 AVISITN*trtn           12   2        -3.16     0.0037     0.05
 AVISITN*trtn           12   3        -3.51     0.0016     0.05

 
 
 
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: In this supplemental analysis, the main ICE of treatm
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.4
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}
Key Seconda
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

                      The Mixed Procedure

                      Least Squares Means
 
                   Analysis
    Effect         Visit (N)    trtn      Lower       Upper

    AVISITN*trtn            1   1       -1.1175    -0.00537
    AVISITN*trtn            1   2       -0.8230      0.1063
    AVISITN*trtn            1   3       -0.7375      0.2370
    AVISITN*trtn            4   1       -1.0616      0.1619
    AVISITN*trtn            4   2       -1.0266    -0.01463
    AVISITN*trtn            4   3       -0.9723      0.1424
    AVISITN*trtn            8   1       -1.4503      0.1200
    AVISITN*trtn            8   2       -1.4760    -0.09043
    AVISITN*trtn            8   3       -1.2265      0.2109
    AVISITN*trtn           12   1       -1.4016     -0.1093
    AVISITN*trtn           12   2       -1.5147     -0.3247
    AVISITN*trtn           12   3       -1.5547     -0.4063
 
 
 
 
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: In this supplemental analysis, the main ICE of treatm
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.4
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}
Key Seconda
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

                      The Mixed Procedure

              Differences of Least Squares Means
 
                Analysis          Analysis
  Effect        Visit (N)   trtn  Visit (N)   _trtn  Estimate

  AVISITN*trtn           1  1              1  2       -0.2031
  AVISITN*trtn           1  1              1  3       -0.3112
  AVISITN*trtn           1  1              4  1       -0.1115
  AVISITN*trtn           1  1              4  2      -0.04080
  AVISITN*trtn           1  1              4  3       -0.1465
  AVISITN*trtn           1  1              8  1        0.1037
  AVISITN*trtn           1  1              8  2        0.2218
  AVISITN*trtn           1  1              8  3      -0.05364
  AVISITN*trtn           1  1             12  1        0.1940
  AVISITN*trtn           1  1             12  2        0.3583
  AVISITN*trtn           1  1             12  3        0.4191
  AVISITN*trtn           1  2              1  3       -0.1081
  AVISITN*trtn           1  2              4  1       0.09154
  AVISITN*trtn           1  2              4  2        0.1623
  AVISITN*trtn           1  2              4  3       0.05659
  AVISITN*trtn           1  2              8  1        0.3068
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: In this supplemental analysis, the main ICE of treatm
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.4
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}
Key Seconda
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

                      The Mixed Procedure

              Differences of Least Squares Means
 
                Analysis          Analysis           Standard
  Effect        Visit (N)   trtn  Visit (N)   _trtn     Error

  AVISITN*trtn           1  1              1  2        0.3218
  AVISITN*trtn           1  1              1  3        0.3258
  AVISITN*trtn           1  1              4  1        0.3026
  AVISITN*trtn           1  1              4  2        0.3526
  AVISITN*trtn           1  1              4  3        0.3692
  AVISITN*trtn           1  1              8  1        0.3690
  AVISITN*trtn           1  1              8  2        0.4200
  AVISITN*trtn           1  1              8  3        0.4278
  AVISITN*trtn           1  1             12  1        0.2679
  AVISITN*trtn           1  1             12  2        0.3785
  AVISITN*trtn           1  1             12  3        0.3676
  AVISITN*trtn           1  2              1  3        0.2816
  AVISITN*trtn           1  2              4  1        0.3605
  AVISITN*trtn           1  2              4  2        0.2502
  AVISITN*trtn           1  2              4  3        0.3341
  AVISITN*trtn           1  2              8  1        0.4305
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: In this supplemental analysis, the main ICE of treatm
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.4
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}
Key Seconda
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

                      The Mixed Procedure

               Differences of Least Squares Means
 
              Analysis          Analysis
Effect        Visit (N)   trtn  Visit (N)   _trtn    DF  t Value

AVISITN*trtn           1  1              1  2        34    -0.63
AVISITN*trtn           1  1              1  3        34    -0.96
AVISITN*trtn           1  1              4  1      27.6    -0.37
AVISITN*trtn           1  1              4  2      57.5    -0.12
AVISITN*trtn           1  1              4  3      58.2    -0.40
AVISITN*trtn           1  1              8  1      25.5     0.28
AVISITN*trtn           1  1              8  2      57.1     0.53
AVISITN*trtn           1  1              8  3      53.1    -0.13
AVISITN*trtn           1  1             12  1      24.2     0.72
AVISITN*trtn           1  1             12  2        52     0.95
AVISITN*trtn           1  1             12  3      49.9     1.14
AVISITN*trtn           1  2              1  3        34    -0.38
AVISITN*trtn           1  2              4  1      51.1     0.25
AVISITN*trtn           1  2              4  2      27.4     0.65
AVISITN*trtn           1  2              4  3      55.9     0.17
AVISITN*trtn           1  2              8  1      43.8     0.71
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: In this supplemental analysis, the main ICE of treatm
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.4
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}
Key Seconda
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

                      The Mixed Procedure

              Differences of Least Squares Means
 
                Analysis          Analysis
  Effect        Visit (N)   trtn  Visit (N)   _trtn  Pr > |t|

  AVISITN*trtn           1  1              1  2        0.5322
  AVISITN*trtn           1  1              1  3        0.3462
  AVISITN*trtn           1  1              4  1        0.7152
  AVISITN*trtn           1  1              4  2        0.9083
  AVISITN*trtn           1  1              4  3        0.6930
  AVISITN*trtn           1  1              8  1        0.7809
  AVISITN*trtn           1  1              8  2        0.5995
  AVISITN*trtn           1  1              8  3        0.9007
  AVISITN*trtn           1  1             12  1        0.4759
  AVISITN*trtn           1  1             12  2        0.3482
  AVISITN*trtn           1  1             12  3        0.2598
  AVISITN*trtn           1  2              1  3        0.7034
  AVISITN*trtn           1  2              4  1        0.8005
  AVISITN*trtn           1  2              4  2        0.5221
  AVISITN*trtn           1  2              4  3        0.8661
  AVISITN*trtn           1  2              8  1        0.4798
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: In this supplemental analysis, the main ICE of treatm
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.4
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}
Key Seconda
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

                      The Mixed Procedure

              Differences of Least Squares Means
 
                 Analysis          Analysis
   Effect        Visit (N)   trtn  Visit (N)   _trtn   Alpha

   AVISITN*trtn           1  1              1  2        0.05
   AVISITN*trtn           1  1              1  3        0.05
   AVISITN*trtn           1  1              4  1        0.05
   AVISITN*trtn           1  1              4  2        0.05
   AVISITN*trtn           1  1              4  3        0.05
   AVISITN*trtn           1  1              8  1        0.05
   AVISITN*trtn           1  1              8  2        0.05
   AVISITN*trtn           1  1              8  3        0.05
   AVISITN*trtn           1  1             12  1        0.05
   AVISITN*trtn           1  1             12  2        0.05
   AVISITN*trtn           1  1             12  3        0.05
   AVISITN*trtn           1  2              1  3        0.05
   AVISITN*trtn           1  2              4  1        0.05
   AVISITN*trtn           1  2              4  2        0.05
   AVISITN*trtn           1  2              4  3        0.05
   AVISITN*trtn           1  2              8  1        0.05
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: In this supplemental analysis, the main ICE of treatm
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.4
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}
Key Seconda
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

                      The Mixed Procedure

              Differences of Least Squares Means
 
                Analysis          Analysis
  Effect        Visit (N)   trtn  Visit (N)   _trtn     Lower

  AVISITN*trtn           1  1              1  2       -0.8570
  AVISITN*trtn           1  1              1  3       -0.9733
  AVISITN*trtn           1  1              4  1       -0.7317
  AVISITN*trtn           1  1              4  2       -0.7467
  AVISITN*trtn           1  1              4  3       -0.8854
  AVISITN*trtn           1  1              8  1       -0.6555
  AVISITN*trtn           1  1              8  2       -0.6193
  AVISITN*trtn           1  1              8  3       -0.9116
  AVISITN*trtn           1  1             12  1       -0.3586
  AVISITN*trtn           1  1             12  2       -0.4012
  AVISITN*trtn           1  1             12  3       -0.3194
  AVISITN*trtn           1  2              1  3       -0.6803
  AVISITN*trtn           1  2              4  1       -0.6320
  AVISITN*trtn           1  2              4  2       -0.3508
  AVISITN*trtn           1  2              4  3       -0.6128
  AVISITN*trtn           1  2              8  1       -0.5610
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: In this supplemental analysis, the main ICE of treatm
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.4
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}
Key Seconda
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

                      The Mixed Procedure

              Differences of Least Squares Means
 
                Analysis          Analysis
  Effect        Visit (N)   trtn  Visit (N)   _trtn     Upper

  AVISITN*trtn           1  1              1  2        0.4509
  AVISITN*trtn           1  1              1  3        0.3509
  AVISITN*trtn           1  1              4  1        0.5086
  AVISITN*trtn           1  1              4  2        0.6651
  AVISITN*trtn           1  1              4  3        0.5924
  AVISITN*trtn           1  1              8  1        0.8630
  AVISITN*trtn           1  1              8  2        1.0629
  AVISITN*trtn           1  1              8  3        0.8044
  AVISITN*trtn           1  1             12  1        0.7467
  AVISITN*trtn           1  1             12  2        1.1178
  AVISITN*trtn           1  1             12  3        1.1575
  AVISITN*trtn           1  2              1  3        0.4641
  AVISITN*trtn           1  2              4  1        0.8151
  AVISITN*trtn           1  2              4  2        0.6754
  AVISITN*trtn           1  2              4  3        0.7259
  AVISITN*trtn           1  2              8  1        1.1746
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: In this supplemental analysis, the main ICE of treatm
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.4
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}
Key Seconda
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

                      The Mixed Procedure

              Differences of Least Squares Means
 
                Analysis          Analysis
  Effect        Visit (N)   trtn  Visit (N)   _trtn  Estimate

  AVISITN*trtn           1  2              8  2        0.4249
  AVISITN*trtn           1  2              8  3        0.1494
  AVISITN*trtn           1  2             12  1        0.3971
  AVISITN*trtn           1  2             12  2        0.5614
  AVISITN*trtn           1  2             12  3        0.6221
  AVISITN*trtn           1  3              4  1        0.1997
  AVISITN*trtn           1  3              4  2        0.2704
  AVISITN*trtn           1  3              4  3        0.1647
  AVISITN*trtn           1  3              8  1        0.4149
  AVISITN*trtn           1  3              8  2        0.5330
  AVISITN*trtn           1  3              8  3        0.2575
  AVISITN*trtn           1  3             12  1        0.5052
  AVISITN*trtn           1  3             12  2        0.6695
  AVISITN*trtn           1  3             12  3        0.7303
  AVISITN*trtn           4  1              4  2       0.07073
  AVISITN*trtn           4  1              4  3      -0.03495
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: In this supplemental analysis, the main ICE of treatm
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.4
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}
Key Seconda
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

                      The Mixed Procedure

              Differences of Least Squares Means
 
                Analysis          Analysis           Standard
  Effect        Visit (N)   trtn  Visit (N)   _trtn     Error

  AVISITN*trtn           1  2              8  2        0.3283
  AVISITN*trtn           1  2              8  3        0.3975
  AVISITN*trtn           1  2             12  1        0.3675
  AVISITN*trtn           1  2             12  2        0.2560
  AVISITN*trtn           1  2             12  3        0.3312
  AVISITN*trtn           1  3              4  1        0.3659
  AVISITN*trtn           1  3              4  2        0.3219
  AVISITN*trtn           1  3              4  3        0.2757
  AVISITN*trtn           1  3              8  1        0.4348
  AVISITN*trtn           1  3              8  2        0.3939
  AVISITN*trtn           1  3              8  3        0.3393
  AVISITN*trtn           1  3             12  1        0.3722
  AVISITN*trtn           1  3             12  2        0.3481
  AVISITN*trtn           1  3             12  3        0.2394
  AVISITN*trtn           4  1              4  2        0.3554
  AVISITN*trtn           4  1              4  3        0.3718
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: In this supplemental analysis, the main ICE of treatm
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.4
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}
Key Seconda
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

                      The Mixed Procedure

               Differences of Least Squares Means
 
              Analysis          Analysis
Effect        Visit (N)   trtn  Visit (N)   _trtn    DF  t Value

AVISITN*trtn           1  2              8  2      28.2     1.29
AVISITN*trtn           1  2              8  3      47.7     0.38
AVISITN*trtn           1  2             12  1      43.4     1.08
AVISITN*trtn           1  2             12  2      25.1     2.19
AVISITN*trtn           1  2             12  3        48     1.88
AVISITN*trtn           1  3              4  1      52.7     0.55
AVISITN*trtn           1  3              4  2      58.6     0.84
AVISITN*trtn           1  3              4  3      28.4     0.60
AVISITN*trtn           1  3              8  1      45.2     0.95
AVISITN*trtn           1  3              8  2      53.9     1.35
AVISITN*trtn           1  3              8  3      26.1     0.76
AVISITN*trtn           1  3             12  1      44.7     1.36
AVISITN*trtn           1  3             12  2        51     1.92
AVISITN*trtn           1  3             12  3      24.1     3.05
AVISITN*trtn           4  1              4  2      27.8     0.20
AVISITN*trtn           4  1              4  3      28.3    -0.09
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: In this supplemental analysis, the main ICE of treatm
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.4
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}
Key Seconda
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

                      The Mixed Procedure

              Differences of Least Squares Means
 
                Analysis          Analysis
  Effect        Visit (N)   trtn  Visit (N)   _trtn  Pr > |t|

  AVISITN*trtn           1  2              8  2        0.2062
  AVISITN*trtn           1  2              8  3        0.7086
  AVISITN*trtn           1  2             12  1        0.2859
  AVISITN*trtn           1  2             12  2        0.0378
  AVISITN*trtn           1  2             12  3        0.0664
  AVISITN*trtn           1  3              4  1        0.5876
  AVISITN*trtn           1  3              4  2        0.4044
  AVISITN*trtn           1  3              4  3        0.5549
  AVISITN*trtn           1  3              8  1        0.3450
  AVISITN*trtn           1  3              8  2        0.1817
  AVISITN*trtn           1  3              8  3        0.4546
  AVISITN*trtn           1  3             12  1        0.1814
  AVISITN*trtn           1  3             12  2        0.0601
  AVISITN*trtn           1  3             12  3        0.0055
  AVISITN*trtn           4  1              4  2        0.8437
  AVISITN*trtn           4  1              4  3        0.9258
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: In this supplemental analysis, the main ICE of treatm
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.4
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}
Key Seconda
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

                      The Mixed Procedure

              Differences of Least Squares Means
 
                 Analysis          Analysis
   Effect        Visit (N)   trtn  Visit (N)   _trtn   Alpha

   AVISITN*trtn           1  2              8  2        0.05
   AVISITN*trtn           1  2              8  3        0.05
   AVISITN*trtn           1  2             12  1        0.05
   AVISITN*trtn           1  2             12  2        0.05
   AVISITN*trtn           1  2             12  3        0.05
   AVISITN*trtn           1  3              4  1        0.05
   AVISITN*trtn           1  3              4  2        0.05
   AVISITN*trtn           1  3              4  3        0.05
   AVISITN*trtn           1  3              8  1        0.05
   AVISITN*trtn           1  3              8  2        0.05
   AVISITN*trtn           1  3              8  3        0.05
   AVISITN*trtn           1  3             12  1        0.05
   AVISITN*trtn           1  3             12  2        0.05
   AVISITN*trtn           1  3             12  3        0.05
   AVISITN*trtn           4  1              4  2        0.05
   AVISITN*trtn           4  1              4  3        0.05
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: In this supplemental analysis, the main ICE of treatm
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.4
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}
Key Seconda
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

                      The Mixed Procedure

              Differences of Least Squares Means
 
                Analysis          Analysis
  Effect        Visit (N)   trtn  Visit (N)   _trtn     Lower

  AVISITN*trtn           1  2              8  2       -0.2475
  AVISITN*trtn           1  2              8  3       -0.6499
  AVISITN*trtn           1  2             12  1       -0.3439
  AVISITN*trtn           1  2             12  2       0.03421
  AVISITN*trtn           1  2             12  3      -0.04369
  AVISITN*trtn           1  3              4  1       -0.5343
  AVISITN*trtn           1  3              4  2       -0.3739
  AVISITN*trtn           1  3              4  3       -0.3997
  AVISITN*trtn           1  3              8  1       -0.4607
  AVISITN*trtn           1  3              8  2       -0.2567
  AVISITN*trtn           1  3              8  3       -0.4398
  AVISITN*trtn           1  3             12  1       -0.2445
  AVISITN*trtn           1  3             12  2      -0.02940
  AVISITN*trtn           1  3             12  3        0.2362
  AVISITN*trtn           4  1              4  2       -0.6576
  AVISITN*trtn           4  1              4  3       -0.7962
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: In this supplemental analysis, the main ICE of treatm
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.4
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}
Key Seconda
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

                      The Mixed Procedure

              Differences of Least Squares Means
 
                Analysis          Analysis
  Effect        Visit (N)   trtn  Visit (N)   _trtn     Upper

  AVISITN*trtn           1  2              8  2        1.0972
  AVISITN*trtn           1  2              8  3        0.9488
  AVISITN*trtn           1  2             12  1        1.1381
  AVISITN*trtn           1  2             12  2        1.0886
  AVISITN*trtn           1  2             12  3        1.2880
  AVISITN*trtn           1  3              4  1        0.9336
  AVISITN*trtn           1  3              4  2        0.9146
  AVISITN*trtn           1  3              4  3        0.7291
  AVISITN*trtn           1  3              8  1        1.2905
  AVISITN*trtn           1  3              8  2        1.3227
  AVISITN*trtn           1  3              8  3        0.9549
  AVISITN*trtn           1  3             12  1        1.2549
  AVISITN*trtn           1  3             12  2        1.3684
  AVISITN*trtn           1  3             12  3        1.2243
  AVISITN*trtn           4  1              4  2        0.7991
  AVISITN*trtn           4  1              4  3        0.7263
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: In this supplemental analysis, the main ICE of treatm
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.4
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}
Key Seconda
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

                      The Mixed Procedure

              Differences of Least Squares Means
 
                Analysis          Analysis
  Effect        Visit (N)   trtn  Visit (N)   _trtn  Estimate

  AVISITN*trtn           4  1              8  1        0.2153
  AVISITN*trtn           4  1              8  2        0.3333
  AVISITN*trtn           4  1              8  3       0.05789
  AVISITN*trtn           4  1             12  1        0.3055
  AVISITN*trtn           4  1             12  2        0.4698
  AVISITN*trtn           4  1             12  3        0.5306
  AVISITN*trtn           4  2              4  3       -0.1057
  AVISITN*trtn           4  2              8  1        0.1445
  AVISITN*trtn           4  2              8  2        0.2626
  AVISITN*trtn           4  2              8  3      -0.01284
  AVISITN*trtn           4  2             12  1        0.2348
  AVISITN*trtn           4  2             12  2        0.3991
  AVISITN*trtn           4  2             12  3        0.4599
  AVISITN*trtn           4  3              8  1        0.2502
  AVISITN*trtn           4  3              8  2        0.3683
  AVISITN*trtn           4  3              8  3       0.09284
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: In this supplemental analysis, the main ICE of treatm
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.4
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}
Key Seconda
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

                      The Mixed Procedure

              Differences of Least Squares Means
 
                Analysis          Analysis           Standard
  Effect        Visit (N)   trtn  Visit (N)   _trtn     Error

  AVISITN*trtn           4  1              8  1        0.2718
  AVISITN*trtn           4  1              8  2        0.4270
  AVISITN*trtn           4  1              8  3        0.4348
  AVISITN*trtn           4  1             12  1        0.3276
  AVISITN*trtn           4  1             12  2        0.4022
  AVISITN*trtn           4  1             12  3        0.3930
  AVISITN*trtn           4  2              4  3        0.3259
  AVISITN*trtn           4  2              8  1        0.4309
  AVISITN*trtn           4  2              8  2        0.2553
  AVISITN*trtn           4  2              8  3        0.3967
  AVISITN*trtn           4  2             12  1        0.3847
  AVISITN*trtn           4  2             12  2        0.2994
  AVISITN*trtn           4  2             12  3        0.3525
  AVISITN*trtn           4  3              8  1        0.4445
  AVISITN*trtn           4  3              8  2        0.4031
  AVISITN*trtn           4  3              8  3        0.2518
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: In this supplemental analysis, the main ICE of treatm
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.4
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}
Key Seconda
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

                      The Mixed Procedure

               Differences of Least Squares Means
 
              Analysis          Analysis
Effect        Visit (N)   trtn  Visit (N)   _trtn    DF  t Value

AVISITN*trtn           4  1              8  1        25     0.79
AVISITN*trtn           4  1              8  2      42.6     0.78
AVISITN*trtn           4  1              8  3      40.3     0.13
AVISITN*trtn           4  1             12  1        27     0.93
AVISITN*trtn           4  1             12  2        52     1.17
AVISITN*trtn           4  1             12  3      50.3     1.35
AVISITN*trtn           4  2              4  3      28.5    -0.32
AVISITN*trtn           4  2              8  1      36.5     0.34
AVISITN*trtn           4  2              8  2      25.3     1.03
AVISITN*trtn           4  2              8  3      39.7    -0.03
AVISITN*trtn           4  2             12  1        47     0.61
AVISITN*trtn           4  2             12  2      29.6     1.33
AVISITN*trtn           4  2             12  3      50.9     1.30
AVISITN*trtn           4  3              8  1      38.1     0.56
AVISITN*trtn           4  3              8  2      44.1     0.91
AVISITN*trtn           4  3              8  3      25.1     0.37
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: In this supplemental analysis, the main ICE of treatm
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.4
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}
Key Seconda
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

                      The Mixed Procedure

              Differences of Least Squares Means
 
                Analysis          Analysis
  Effect        Visit (N)   trtn  Visit (N)   _trtn  Pr > |t|

  AVISITN*trtn           4  1              8  1        0.4359
  AVISITN*trtn           4  1              8  2        0.4394
  AVISITN*trtn           4  1              8  3        0.8947
  AVISITN*trtn           4  1             12  1        0.3593
  AVISITN*trtn           4  1             12  2        0.2481
  AVISITN*trtn           4  1             12  3        0.1830
  AVISITN*trtn           4  2              4  3        0.7481
  AVISITN*trtn           4  2              8  1        0.7392
  AVISITN*trtn           4  2              8  2        0.3135
  AVISITN*trtn           4  2              8  3        0.9743
  AVISITN*trtn           4  2             12  1        0.5446
  AVISITN*trtn           4  2             12  2        0.1927
  AVISITN*trtn           4  2             12  3        0.1979
  AVISITN*trtn           4  3              8  1        0.5768
  AVISITN*trtn           4  3              8  2        0.3659
  AVISITN*trtn           4  3              8  3        0.7154
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: In this supplemental analysis, the main ICE of treatm
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.4
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}
Key Seconda
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

                      The Mixed Procedure

              Differences of Least Squares Means
 
                 Analysis          Analysis
   Effect        Visit (N)   trtn  Visit (N)   _trtn   Alpha

   AVISITN*trtn           4  1              8  1        0.05
   AVISITN*trtn           4  1              8  2        0.05
   AVISITN*trtn           4  1              8  3        0.05
   AVISITN*trtn           4  1             12  1        0.05
   AVISITN*trtn           4  1             12  2        0.05
   AVISITN*trtn           4  1             12  3        0.05
   AVISITN*trtn           4  2              4  3        0.05
   AVISITN*trtn           4  2              8  1        0.05
   AVISITN*trtn           4  2              8  2        0.05
   AVISITN*trtn           4  2              8  3        0.05
   AVISITN*trtn           4  2             12  1        0.05
   AVISITN*trtn           4  2             12  2        0.05
   AVISITN*trtn           4  2             12  3        0.05
   AVISITN*trtn           4  3              8  1        0.05
   AVISITN*trtn           4  3              8  2        0.05
   AVISITN*trtn           4  3              8  3        0.05
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: In this supplemental analysis, the main ICE of treatm
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.4
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}
Key Seconda
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

                      The Mixed Procedure

              Differences of Least Squares Means
 
                Analysis          Analysis
  Effect        Visit (N)   trtn  Visit (N)   _trtn     Lower

  AVISITN*trtn           4  1              8  1       -0.3446
  AVISITN*trtn           4  1              8  2       -0.5280
  AVISITN*trtn           4  1              8  3       -0.8208
  AVISITN*trtn           4  1             12  1       -0.3667
  AVISITN*trtn           4  1             12  2       -0.3373
  AVISITN*trtn           4  1             12  3       -0.2587
  AVISITN*trtn           4  2              4  3       -0.7728
  AVISITN*trtn           4  2              8  1       -0.7289
  AVISITN*trtn           4  2              8  2       -0.2630
  AVISITN*trtn           4  2              8  3       -0.8148
  AVISITN*trtn           4  2             12  1       -0.5392
  AVISITN*trtn           4  2             12  2       -0.2127
  AVISITN*trtn           4  2             12  3       -0.2478
  AVISITN*trtn           4  3              8  1       -0.6495
  AVISITN*trtn           4  3              8  2       -0.4441
  AVISITN*trtn           4  3              8  3       -0.4257
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: In this supplemental analysis, the main ICE of treatm
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.4
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}
Key Seconda
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

                      The Mixed Procedure

              Differences of Least Squares Means
 
                Analysis          Analysis
  Effect        Visit (N)   trtn  Visit (N)   _trtn     Upper

  AVISITN*trtn           4  1              8  1        0.7751
  AVISITN*trtn           4  1              8  2        1.1947
  AVISITN*trtn           4  1              8  3        0.9365
  AVISITN*trtn           4  1             12  1        0.9777
  AVISITN*trtn           4  1             12  2        1.2770
  AVISITN*trtn           4  1             12  3        1.3199
  AVISITN*trtn           4  2              4  3        0.5615
  AVISITN*trtn           4  2              8  1        1.0180
  AVISITN*trtn           4  2              8  2        0.7882
  AVISITN*trtn           4  2              8  3        0.7891
  AVISITN*trtn           4  2             12  1        1.0088
  AVISITN*trtn           4  2             12  2        1.0109
  AVISITN*trtn           4  2             12  3        1.1676
  AVISITN*trtn           4  3              8  1        1.1499
  AVISITN*trtn           4  3              8  2        1.1807
  AVISITN*trtn           4  3              8  3        0.6114
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: In this supplemental analysis, the main ICE of treatm
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.4
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}
Key Seconda
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

                      The Mixed Procedure

              Differences of Least Squares Means
 
                Analysis          Analysis
  Effect        Visit (N)   trtn  Visit (N)   _trtn  Estimate

  AVISITN*trtn           4  3             12  1        0.3405
  AVISITN*trtn           4  3             12  2        0.5048
  AVISITN*trtn           4  3             12  3        0.5656
  AVISITN*trtn           8  1              8  2        0.1181
  AVISITN*trtn           8  1              8  3       -0.1574
  AVISITN*trtn           8  1             12  1       0.09027
  AVISITN*trtn           8  1             12  2        0.2546
  AVISITN*trtn           8  1             12  3        0.3153
  AVISITN*trtn           8  2              8  3       -0.2754
  AVISITN*trtn           8  2             12  1      -0.02779
  AVISITN*trtn           8  2             12  2        0.1365
  AVISITN*trtn           8  2             12  3        0.1973
  AVISITN*trtn           8  3             12  1        0.2476
  AVISITN*trtn           8  3             12  2        0.4119
  AVISITN*trtn           8  3             12  3        0.4727
  AVISITN*trtn          12  1             12  2        0.1643
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: In this supplemental analysis, the main ICE of treatm
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.4
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}
Key Seconda
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

                      The Mixed Procedure

              Differences of Least Squares Means
 
                Analysis          Analysis           Standard
  Effect        Visit (N)   trtn  Visit (N)   _trtn     Error

  AVISITN*trtn           4  3             12  1        0.4003
  AVISITN*trtn           4  3             12  2        0.3792
  AVISITN*trtn           4  3             12  3        0.2963
  AVISITN*trtn           8  1              8  2        0.4602
  AVISITN*trtn           8  1              8  3        0.4736
  AVISITN*trtn           8  1             12  1        0.3114
  AVISITN*trtn           8  1             12  2        0.4532
  AVISITN*trtn           8  1             12  3        0.4478
  AVISITN*trtn           8  2              8  3        0.4239
  AVISITN*trtn           8  2             12  1        0.4340
  AVISITN*trtn           8  2             12  2        0.2900
  AVISITN*trtn           8  2             12  3        0.4031
  AVISITN*trtn           8  3             12  1        0.4448
  AVISITN*trtn           8  3             12  2        0.4206
  AVISITN*trtn           8  3             12  3        0.2816
  AVISITN*trtn          12  1             12  2        0.3678
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: In this supplemental analysis, the main ICE of treatm
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.4
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}
Key Seconda
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

                      The Mixed Procedure

               Differences of Least Squares Means
 
              Analysis          Analysis
Effect        Visit (N)   trtn  Visit (N)   _trtn    DF  t Value

AVISITN*trtn           4  3             12  1      49.5     0.85
AVISITN*trtn           4  3             12  2      54.1     1.33
AVISITN*trtn           4  3             12  3      26.5     1.91
AVISITN*trtn           8  1              8  2      27.7     0.26
AVISITN*trtn           8  1              8  3      27.4    -0.33
AVISITN*trtn           8  1             12  1      26.4     0.29
AVISITN*trtn           8  1             12  2      41.5     0.56
AVISITN*trtn           8  1             12  3      40.1     0.70
AVISITN*trtn           8  2              8  3      28.5    -0.65
AVISITN*trtn           8  2             12  1      44.4    -0.06
AVISITN*trtn           8  2             12  2      28.5     0.47
AVISITN*trtn           8  2             12  3      45.9     0.49
AVISITN*trtn           8  3             12  1        43     0.56
AVISITN*trtn           8  3             12  2      45.2     0.98
AVISITN*trtn           8  3             12  3      25.9     1.68
AVISITN*trtn          12  1             12  2      25.9     0.45
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: In this supplemental analysis, the main ICE of treatm
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.4
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}
Key Seconda
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

                      The Mixed Procedure

              Differences of Least Squares Means
 
                Analysis          Analysis
  Effect        Visit (N)   trtn  Visit (N)   _trtn  Pr > |t|

  AVISITN*trtn           4  3             12  1        0.3991
  AVISITN*trtn           4  3             12  2        0.1887
  AVISITN*trtn           4  3             12  3        0.0672
  AVISITN*trtn           8  1              8  2        0.7994
  AVISITN*trtn           8  1              8  3        0.7422
  AVISITN*trtn           8  1             12  1        0.7742
  AVISITN*trtn           8  1             12  2        0.5773
  AVISITN*trtn           8  1             12  3        0.4854
  AVISITN*trtn           8  2              8  3        0.5211
  AVISITN*trtn           8  2             12  1        0.9492
  AVISITN*trtn           8  2             12  2        0.6415
  AVISITN*trtn           8  2             12  3        0.6269
  AVISITN*trtn           8  3             12  1        0.5806
  AVISITN*trtn           8  3             12  2        0.3326
  AVISITN*trtn           8  3             12  3        0.1053
  AVISITN*trtn          12  1             12  2        0.6588
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: In this supplemental analysis, the main ICE of treatm
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.4
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}
Key Seconda
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

                      The Mixed Procedure

              Differences of Least Squares Means
 
                 Analysis          Analysis
   Effect        Visit (N)   trtn  Visit (N)   _trtn   Alpha

   AVISITN*trtn           4  3             12  1        0.05
   AVISITN*trtn           4  3             12  2        0.05
   AVISITN*trtn           4  3             12  3        0.05
   AVISITN*trtn           8  1              8  2        0.05
   AVISITN*trtn           8  1              8  3        0.05
   AVISITN*trtn           8  1             12  1        0.05
   AVISITN*trtn           8  1             12  2        0.05
   AVISITN*trtn           8  1             12  3        0.05
   AVISITN*trtn           8  2              8  3        0.05
   AVISITN*trtn           8  2             12  1        0.05
   AVISITN*trtn           8  2             12  2        0.05
   AVISITN*trtn           8  2             12  3        0.05
   AVISITN*trtn           8  3             12  1        0.05
   AVISITN*trtn           8  3             12  2        0.05
   AVISITN*trtn           8  3             12  3        0.05
   AVISITN*trtn          12  1             12  2        0.05
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: In this supplemental analysis, the main ICE of treatm
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.4
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}
Key Seconda
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

                      The Mixed Procedure

              Differences of Least Squares Means
 
                Analysis          Analysis
  Effect        Visit (N)   trtn  Visit (N)   _trtn     Lower

  AVISITN*trtn           4  3             12  1       -0.4637
  AVISITN*trtn           4  3             12  2       -0.2554
  AVISITN*trtn           4  3             12  3      -0.04304
  AVISITN*trtn           8  1              8  2       -0.8251
  AVISITN*trtn           8  1              8  3       -1.1284
  AVISITN*trtn           8  1             12  1       -0.5493
  AVISITN*trtn           8  1             12  2       -0.6603
  AVISITN*trtn           8  1             12  3       -0.5897
  AVISITN*trtn           8  2              8  3       -1.1431
  AVISITN*trtn           8  2             12  1       -0.9022
  AVISITN*trtn           8  2             12  2       -0.4571
  AVISITN*trtn           8  2             12  3       -0.6142
  AVISITN*trtn           8  3             12  1       -0.6493
  AVISITN*trtn           8  3             12  2       -0.4350
  AVISITN*trtn           8  3             12  3       -0.1063
  AVISITN*trtn          12  1             12  2       -0.5918
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: In this supplemental analysis, the main ICE of treatm
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.4
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}
Key Seconda
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

                      The Mixed Procedure

              Differences of Least Squares Means
 
                Analysis          Analysis
  Effect        Visit (N)   trtn  Visit (N)   _trtn     Upper

  AVISITN*trtn           4  3             12  1        1.1446
  AVISITN*trtn           4  3             12  2        1.2650
  AVISITN*trtn           4  3             12  3        1.1741
  AVISITN*trtn           8  1              8  2        1.0612
  AVISITN*trtn           8  1              8  3        0.8137
  AVISITN*trtn           8  1             12  1        0.7299
  AVISITN*trtn           8  1             12  2        1.1695
  AVISITN*trtn           8  1             12  3        1.2203
  AVISITN*trtn           8  2              8  3        0.5923
  AVISITN*trtn           8  2             12  1        0.8466
  AVISITN*trtn           8  2             12  2        0.7302
  AVISITN*trtn           8  2             12  3        1.0088
  AVISITN*trtn           8  3             12  1        1.1446
  AVISITN*trtn           8  3             12  2        1.2589
  AVISITN*trtn           8  3             12  3        1.0517
  AVISITN*trtn          12  1             12  2        0.9204
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: In this supplemental analysis, the main ICE of treatm
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.4
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}
Key Seconda
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

                      The Mixed Procedure

              Differences of Least Squares Means
 
                Analysis          Analysis
  Effect        Visit (N)   trtn  Visit (N)   _trtn  Estimate

  AVISITN*trtn          12  1             12  3        0.2251
  AVISITN*trtn          12  2             12  3       0.06076

              Differences of Least Squares Means
 
                Analysis          Analysis           Standard
  Effect        Visit (N)   trtn  Visit (N)   _trtn     Error

  AVISITN*trtn          12  1             12  3        0.3641
  AVISITN*trtn          12  2             12  3        0.3398

 
 
 
 
 
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: In this supplemental analysis, the main ICE of treatm
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.4
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}
Key Seconda
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

                      The Mixed Procedure

               Differences of Least Squares Means
 
              Analysis          Analysis
Effect        Visit (N)   trtn  Visit (N)   _trtn    DF  t Value

AVISITN*trtn          12  1             12  3      25.1     0.62
AVISITN*trtn          12  2             12  3      27.2     0.18

              Differences of Least Squares Means
 
                Analysis          Analysis
  Effect        Visit (N)   trtn  Visit (N)   _trtn  Pr > |t|

  AVISITN*trtn          12  1             12  3        0.5421
  AVISITN*trtn          12  2             12  3        0.8594

 
 
 
 
 
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: In this supplemental analysis, the main ICE of treatm
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.4
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}
Key Seconda
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

                      The Mixed Procedure

              Differences of Least Squares Means
 
                 Analysis          Analysis
   Effect        Visit (N)   trtn  Visit (N)   _trtn   Alpha

   AVISITN*trtn          12  1             12  3        0.05
   AVISITN*trtn          12  2             12  3        0.05

              Differences of Least Squares Means
 
                Analysis          Analysis
  Effect        Visit (N)   trtn  Visit (N)   _trtn     Lower

  AVISITN*trtn          12  1             12  3       -0.5247
  AVISITN*trtn          12  2             12  3       -0.6361

 
 
 
 
 
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: In this supplemental analysis, the main ICE of treatm
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.4
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}
Key Seconda
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

                      The Mixed Procedure

              Differences of Least Squares Means
 
                Analysis          Analysis
  Effect        Visit (N)   trtn  Visit (N)   _trtn     Upper

  AVISITN*trtn          12  1             12  3        0.9748
  AVISITN*trtn          12  2             12  3        0.7577
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: In this supplemental analysis, the main ICE of treatm
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
